Grace Therapeutics, Inc. SEC filings GRCE

Grace Therapeutics, Inc. has 594 filings in SEC EDGAR's recent list, going back to Sep 2, 2008. Its latest annual report, Form 10-K, was filed on Jun 18, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (shareholder vote results). The company's fiscal year ends on March 31.

Grace Therapeutics, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 5, 2026 Nov 3, 2026
4 Insider transaction Oct 26, 2026 Oct 22, 2026
4 Insider transaction Oct 21, 2026 Oct 19, 2026
4 Insider transaction Oct 16, 2026 Oct 14, 2026
4 Insider transaction Oct 13, 2026 Oct 8, 2026
4 Insider transaction Oct 5, 2026 Oct 1, 2026
4 Insider transaction Oct 1, 2026 Sep 29, 2026
4/A Filing Oct 1, 2026 Sep 21, 2026
4 Insider transaction Sep 23, 2026 Sep 21, 2026
4 Insider transaction Sep 21, 2026 Sep 17, 2026
4 Insider transaction Sep 21, 2026 Sep 17, 2026
4 Insider transaction Sep 21, 2026 Sep 17, 2026
4 Insider transaction Sep 21, 2026 Sep 17, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 10, 2026 Sep 9, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
4 Insider transaction Aug 19, 2026 Aug 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 28, 2026 —
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 8, 2025 —
4 Insider transaction Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 29, 2025 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
3/A Primary document Jul 11, 2024 Jun 28, 2024
SC 13G Ownership over 5% (passive) Jul 10, 2024 —
3 Initial insider ownership Jul 9, 2024 Jun 28, 2024
4/A Filing May 10, 2024 May 6, 2024
4/A Filing May 10, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
SC 13G Ownership over 5% (passive) Apr 9, 2024 —
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
3 Initial insider ownership Jan 8, 2024 Jan 5, 2024
4 Insider transaction Dec 20, 2023 Dec 19, 2023
4 Insider transaction Dec 20, 2023 Dec 19, 2023
4 Insider transaction Dec 20, 2023 Dec 19, 2023
4 Insider transaction Dec 20, 2023 Dec 19, 2023
4 Insider transaction Dec 20, 2023 Dec 19, 2023
3 Initial insider ownership Oct 20, 2023 Oct 10, 2023
3 Initial insider ownership Oct 20, 2023 Oct 10, 2023
3 Initial insider ownership Oct 20, 2023 Oct 10, 2023
4 Insider transaction Sep 27, 2023 Sep 25, 2023
4 Insider transaction Sep 5, 2023 Aug 31, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
3 Initial insider ownership May 26, 2023 May 8, 2023
3 Initial insider ownership May 18, 2023 May 8, 2023
3 Initial insider ownership May 18, 2023 May 8, 2023
4 Insider transaction Sep 30, 2022 Sep 28, 2022
4 Insider transaction Sep 30, 2022 Sep 28, 2022
4 Insider transaction Sep 30, 2022 Sep 28, 2022
4 Insider transaction Sep 30, 2022 Sep 28, 2022
3 Initial insider ownership Sep 16, 2022 Sep 9, 2022
4 Insider transaction Jun 23, 2022 Jun 22, 2022
4 Insider transaction Jun 23, 2022 Jun 22, 2022
4 Insider transaction Jun 23, 2022 Jun 22, 2022
4 Insider transaction Jun 23, 2022 Jun 22, 2022
3 Initial insider ownership Apr 1, 2022 Mar 24, 2022
3 Initial insider ownership Nov 23, 2021 Nov 10, 2021
4 Insider transaction Nov 16, 2021 Nov 12, 2021
4 Insider transaction Nov 16, 2021 Nov 12, 2021
4 Insider transaction Nov 16, 2021 Nov 12, 2021
4 Insider transaction Nov 16, 2021 Nov 12, 2021
4 Insider transaction Nov 16, 2021 Nov 12, 2021
4 Insider transaction Nov 16, 2021 Nov 12, 2021
4 Insider transaction Nov 16, 2021 Nov 12, 2021
4 Insider transaction Nov 16, 2021 Nov 12, 2021
3 Initial insider ownership Nov 3, 2021 Aug 27, 2021
3 Initial insider ownership Sep 28, 2021 Aug 27, 2021
3 Initial insider ownership Sep 23, 2021 Aug 27, 2021
3 Initial insider ownership Sep 23, 2020 Sep 14, 2020
3 Initial insider ownership Apr 1, 2020 Apr 1, 2020
3 Initial insider ownership Apr 1, 2020 Apr 1, 2020
3 Initial insider ownership Apr 1, 2020 Apr 1, 2020
3 Initial insider ownership Apr 1, 2020 Apr 1, 2020
3 Initial insider ownership Apr 1, 2020 Apr 1, 2020
3 Initial insider ownership Apr 1, 2020 Apr 1, 2020
3 Initial insider ownership Apr 1, 2020 Apr 1, 2020
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2020 —
SC 13D/A Amended ownership over 5% (active) Aug 1, 2019 —
SC 13G Ownership over 5% (passive) Jul 19, 2019 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2019 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2018 —
SC 13G Ownership over 5% (passive) Mar 22, 2017 —
3 Initial insider ownership Feb 22, 2017 Feb 21, 2017
SC 13D/A Amended ownership over 5% (active) Sep 9, 2015 —
SC 13D Ownership over 5% (active) Dec 18, 2013 —

Showing 121 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GRCE (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Princeton, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1444192
Former names
Acasti Pharma Inc. (until Oct 25, 2024)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.